潜在由多个因素引发的急性无补偿右心力衰竭,包括在血交换期间去除肺血管扩展剂:一个病例报告
Takayuki Toki1, Kazuyuki Mizunoya2, Misa Itabashi2
1Department of Anesthesiology and Critical Care Medicine, Hokkaido University Hospital, N14W5, Kita-ku, Sapporo, 060-8648, Japan. t.toki1985@outlook.jp.
JA clinical reports
|January 27, 2025
概括
血交换 (PE) 在抗中性粒细胞质抗体相关血管炎 (AAV) 患者中可能引起罕见的休克. 这种情况表明,休克是由于肺血管阻力增加而引起的,可能是由于PE期间的西尔代纳菲尔去除.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
背景情况:
- 血交换 (PE) 用于抗中性粒细胞质抗体相关的血管炎 (AAV) 与膜出血.
- 在PE期间的低血压并不常见,通常与过敏反应有关.
- 这份报告详细介绍了PE期间罕见的休克病例,该病例归因于肺血管阻力升高 (PVR).
研究的目的:
- 报告患有AAV和肺高血压的患者在血交换期间发生的循环休克病例.
- 在这种特定的临床场景中,研究PE期间增加PVR和休克的潜在原因.
主要方法:
- 一名66岁的男性患有肺高血压 (PH) 和淋巴结膜炎,出现呼吸不良和疑似AAV与气囊出血.
- 血交换 (PE) 被启动,导致患者发展为循环衰竭和高乳糖血症.
- 心声图显示右心室扩张,并注入吸入的氧化 (iNO),改善了患者的病情.
主要成果:
- 患者在开始PE后不久经历了循环衰竭和高乳糖血症.
- 心声显示PVR增加与右心室扩张.
- 服用iNO导致高乳糖血症和氧化率的快速改善.
结论:
- 这种冲击被归因于急性右心力衰竭,这是PH恶化的次要原因.
- 在PE期间的西尔德纳菲尔去除被认为是增加PVR的潜在因素.
- 虽然西尔德纳菲尔取消是可能的原因,但其他因素不能被明确排除.
更多相关视频
相关概念视频
Imbalances in Cardiac Output
1.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.3K
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Acute Respiratory Failure-II
166
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
166
Heart Failure Drugs: Diuretics
338
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
338
Acute Respiratory Failure-V
122
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
122
Acute Respiratory Failure-III
153
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
153


